Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Background. Monoclonal antibodies (mAbs) directed against the calcitonin gene-related peptide (CGRP) or its receptor represented the first targeted and specialized approach to migraine prophylaxis. Nevertheless, they have been rarely considered in the treatment of vestibular migraine (VM). Our aim was to evaluate the effectiveness of anti-CGRP mAbs...
Alternative Titles
Full title
Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_db2017c7c53e45ee8875b3fa9ece5cee
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_db2017c7c53e45ee8875b3fa9ece5cee
Other Identifiers
ISSN
1648-9144,1010-660X
E-ISSN
1648-9144
DOI
10.3390/medicina59091560
